Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease
2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …

BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and
globulins, is associated with thrombotic complications, organ failure, and higher mortality in …

Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

In line with SARS and MERS, the SARS-CoV-2/COVID-19 pandemic is one of the largest
challenges in medicine and health care worldwide. SARS-CoV-2 infection/COVID-19 …

A sudden outbreak of COVID-19 caused by a novel coronavirus, SARS-CoV-2, in Wuhan,
China in December 2019 quickly grew into a global pandemic, putting at risk not only the …

COVID-19 vaccine is the hope for containment of disease outbreak. The post vaccination
adverse effect is an important consideration. The clot after vaccination is an emerging …

Background Recent data suggests an association between blood hyperviscosity and both
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …

To the Editor, Obesity, hypertension, diabetes, and specific ethnicities (Black and Hispanic)
have been reported to be common comorbidities and possible risk factors for the severity of …